| Name | Title | Contact Details |
|---|
Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.
Chemogen is a South Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Eagle Instruments is a Missoula, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Enlitic is focused on developing solutions that enhance clinical workflows, enable research and development, improve billing accuracy, and decrease risk. We`re not an AI company that only produces algorithms for detection and prioritization of specific diseases – point solutions. We`re a medical intelligence company that delivers solutions with a point; to enable better patient outcomes by enhancing what`s possible in data processes. We are working to eliminate inefficiencies in workflows and ensure medical information is more useful and more impactful for patient care.
Bovie Medical is setting the standard for surgi-center and hospital-based electrosurgical generators and accessories with a range of “state of the art” models: the Aaron 900™, the Aaron 940™, the Aaron 950™, the Aaron 1250™, the Aaron 2250™, and the Aaron 3250™ along with the IDS-200™, IDS-300™, and ICON Gi™. This full line is the most complete offering of any USA manufactured electrosurgical generator product. The feature-packed generators are designed from the ground up to be extremely reliable, and are UL and Canadian Standards compliant. All of these generators are available for private labeling. Over the past decade, we have expanded our manufacturing capabilities to include a full line of disposable electrosurgical electrodes in blade, ball, needle, loop and laparoscopic form. The reusable ES pencils, with a full compliment of reusable electrodes and bipolar forceps, enhance our ever-expanding line of products. In addition to electrosurgery, Bovie Medical is the number-one producer of battery-operated cauteries in the world. Its product lines, distribution channels, and renowned industry reputation continue to grow. Bovie Medical continues to improve and expand its product offerings and services, as well as continuing its excellent record of support to existing customers.